Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Pharmaceuticals & Biotech
Create a narrative
Acrux Community
ASX:ACR Community
1
Narratives
written by author
0
Comments
on narratives written by author
15
Fair Values set
on narratives written by author
Create a narrative
Acrux
Popular
Undervalued
Overvalued
Community Investing Ideas
Acrux
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
New Product Launches Including Cone 75% Will Expand Market Presence
Key Takeaways Expansion into niche markets and strategic licensing agreements are aimed at enhancing net margins and diversifying revenue streams. Product pipeline growth coupled with a strong financial position supports sustained long-term revenue and earnings growth.
View narrative
AU$0.09
FV
74.4% undervalued
intrinsic discount
196.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
10 days ago
author updated this narrative
Your Valuation for
ACR
ACR
Acrux
Your Fair Value
AU$
Current Price
AU$0.023
64.3% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-15m
29m
2015
2018
2021
2024
2025
2027
2030
Revenue AU$8.5m
Earnings AU$1.2m
Advanced
Set Fair Value